You are not alone.

Connect with someone who has walked the same journey as you

Talking with someone who has gone through a similar health journey and faced similar challenges can be valuable.

myMentor is an informational resource established by Bayer for adult patients living with pulmonary arterial hypertension (PAH) (WHO Group 1) or chronic thromboembolic pulmonary hypertension (CTEPH) (WHO Group 4), as well as patients who may be considering or starting treatment with Adempas (riociguat) tablets. The program is also offered to caregivers who are interested in learning more about living with PAH or CTEPH.

Through myMentor you can speak privately, one-on-one with a person (called a “Mentor”) who has personal experience living with PAH or CTEPH. They are available to offer support and insight as you continue your journey.

Adempas is a prescription medicine used to treat adults with:

  • Chronic thromboembolic pulmonary hypertension (CTEPH) (WHO Group 4) treated with surgery but who continue to have high pulmonary blood pressure (persistent) or it comes back after surgery (recurrent), or that cannot be treated with surgery (inoperable).
  • Pulmonary arterial hypertension (PAH) (WHO Group 1).

The Adempas clinical studies included mostly patients with WHO Functional Class II–III symptoms. It is not known if Adempas is safe and effective in children.